Table 1.

Retrospective studies on COVID-19-associated hypolipidemia.

Study Population	Lipid Changes in COVID-19	References
519 severe COVID-19 patients from the West Court of Union Hospital in Wuhan, China	Decrease of TC and HDL-C in non-survivors vs survivors	[80]
114 COVID-19 patients from Wenzhou Central Hospital, in Wenzhou, China	Decrease of TC, LDL-C and HDL-C in COVID-19 patients vs healthy controls Decrease of HDL-C in severe vs common groups	[81]
597 COVID-19 patients from the Cancer Center, Union Hospital of Tongji Medical College, Wuhan	Decrease of TC, LDL-C and HDL-C in COVID-19 patients vs healthy controls Decrease of TC and LDL-C in with disease severity	[82]
115 COVID-19 patients from Union Hospital of Tongji Medical College affiliated Huazhong University of Science and Technology	Decrease of HDL-C in COVID-19 patients vs healthy controls	[83]
228 COVID-19 patients from Public Health Treatment Center of Changsha, China	Decrease of TC, LDL-C and HDL-C in COVID-19 patients vs healthy controls Decrease of HDL-C in with disease severity	[84]
17 surviving and 4 non-surviving COVID-19 patients from Zhongnan Hospital of Wuhan University in Wuhan, China	Decrease of TC, LDL-C and HDL-C in non-survivors vs survivors Decrease of LDL-C in with disease severity	[85]
99 COVID-19 patients from Leishenshan Hospital in Wuhan, China.	Decrease of HDL-C in with disease severity	[87]

TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol.